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CASE STUDY
Diffuse alveolar hemorrhage after use 
of a fluoropolymer-based waterproofing spray
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Abstract 
A 30-year-old man developed chills, cough and dyspnea a few minutes after using a fluoropolymer-based waterproof-
ing spray in a small closed room. He visited our hospital 1 h later. Examination revealed that the patient had incessant 
cough, tachypnea, fever and decreased peripheral arterial oxygen saturation. Blood tests revealed leukocytosis with 
elevated serum C-reactive protein levels. Chest radiographs and computed tomography (CT) scan showed bilateral 
ground glass opacities, mainly in the upper lobes. Bronchoalveolar lavage (BAL) fluid obtained from the right middle 
lobe showed a bloody appearance. Microscopic examination of a BAL cytospin specimen revealed the presence of 
numerous red blood cells associated with extreme neutrophilia. Microbiological studies of the BAL fluid were nega-
tive. The patient was observed without corticosteroid therapy, and his symptoms and abnormal shadows on the 
chest radiographs and CT improved. On day 7 after admission, the patient was discharged from the hospital. Acciden-
tal inhalation of waterproofing spray may cause diffuse alveolar hemorrhage, a rare manifestation of acute lung injury. 
Supportive treatment may be effective and sufficient.
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Case presentation
A 30-year-old Japanese male, a smoker with no signifi-
cant past medical, allergy or cocaine use history, devel-
oped chills, cough and dyspnea a few minutes after 
using a fluoropolymer-based waterproofing spray on his 
leather uniforms in a small closed room. He presented 
to our hospital 1  h later. Examination revealed that the 
patient had incessant cough, tachypnea (30 breaths per 
minute), fever (39.4°C) and slightly decreased peripheral 
arterial oxygen saturation [percutaneous oxygen satura-
tion (SpO2): 92% on room air]; however, there were no 
lung crackles or wheeze. Examination of the cardiovas-
cular system revealed no abnormalities. There was no 
weight loss, arthralgia or skin rash. As shown in Table 1, 
the blood tests revealed leukocytosis [20,300  cells/μL 
(normal, 4,000–8,000 cells/μL) with 91.5% neutrophils, 
0% eosinophils and 6.5% lymphocytes], elevated serum 
C-reactive protein levels [3.14 mg/dL (normal, <0.3 mg/
dL)] and elevated serum LDH levels [341  U/l (normal, 
106–220  U/l)]. Autoimmune screening, including for 
anti-neutrophil cytoplasm antibody (ANCA) and anti-
glomerular basement membrane (anti-GBM) antibody, 
revealed no autoantibodies. The serum brain natriu-
retic peptide (BNP) level and coagulation profile were 
normal. Urinalysis showed no proteinuria or hematu-
ria. Chest radiographs and computed tomography (CT) 
scan showed bilateral ground glass opacities, mainly in 
the upper lobes (Figure 1). Fiberoptic bronchoscopy was 
performed 13  h after the onset of the symptoms. Bron-
choalveolar lavage (BAL) fluid obtained from the right 
middle lobe showed a bloody appearance (Figure 2, left). 
While the upper lobes appeared to be predominantly 
involved, the middle lobe was selected for obtaining the 
BAL sample, because this lobe is the smallest and yields 
the largest return (Baughman 2007). Microscopic exami-
nation of a BAL cytospin specimen revealed the presence 
of numerous red blood cells with extreme neutrophilia 
(differential neutrophil count 79.8%, normal range <3%) 
(Figure 2, right). The siderophage count was less than 2%. 
Microbiological studies of the BAL fluid were negative. 
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The patient was observed without corticosteroid therapy, 
and his symptoms improved significantly by the day after 
admission. By day 7 after admission, the abnormal shad-
ows on the chest radiographs and CT scan had almost 
completely disappeared and the patient was discharged 
from the hospital. At 6 months after discharge, his health 
status was normal. Consent to publish this case report 
was obtained from the patient.  
Discussion
Accidental inhalation of waterproofing spray has been 
reported to cause lung injury (Vernez et  al. 2006). Dif-
fuse alveolar hemorrhage (DAH) is a rare, but serious 
manifestation of acute lung injury (Fukui et  al. 2011). 
DAH in this patient was unlikely to be due to immune 
causes such as microscopic polyangiitis, systemic lupus 
erythematosus or Goodpasture’s syndrome, because of 
the absence of weight loss, arthralgia, proteinuria, hema-
turia, anti-nuclear antibody, anti–anti-GBM antibody or 
ANCA (Picard et al. 2010). Furthermore, neither conges-
tive heart failure nor coagulopathy could be considered 
as the likely cause of the DAH, because the serum BNP 
level and coagulation profile were normal.
The toxicity of waterproofing sprays is thought to be 
due to their content of water-repellents, such as fluoro-
polymers and silicon polymers, or of the solvent in which 
they are delivered (Picard et  al. 2010). Among different 
repelling agents, fluoropolymers have been the most 
studied with regard to their toxicity following inhalation 
(Hays and Spiller 2014). An animal study in mice dem-
onstrated that inhalation of fluoropolymers resulted in 
pulmonary collapse and pneumonia, probably by coun-
teracting the surfactant action in the alveoli of the lung, 
whereas mice exposed to non-fluoropolymer-containing 
products showed less severe injury (Yamashita and Tan-
aka 1995). These findings suggest that the fluoropolymer 
Table 1 Laboratory data on admission
Hematology
 White blood cells 20,300/μl (H)
  Neutrophils 91.5% (H)
  Eosinophils 0.0%
  Basophils 0.0%
  Lymphocytes 6.5%
  Monocytes 2.0%
 Hemoglobin 16.5 g/dl
 Platelets 273,000/μl
Biochemistry
 Total protein 7.0 g/dl
 Albumin 4.6 g/dl
 Blood urea nitrogen 11.5 mg/dl
 Creatinine 0.97 mg/dl
 Lactate dehydrogenase 341 U/l (H)
 Aspartate aminotransferase 26 U/l
 Alanine aminotransferase 12 U/l
Coagulation
 PT-INR 1.06
 APTT 29.5 s
 APTT (control) 34.0 s
Serology
 C-reactive protein 3.14 mg/dl (H)
 KL-6 339 U/ml
 Surfactant protein-D 17.2 ng/ml
 B-D-glucan <6.0 pg/ml
 Brain natriuretic peptide 10.2 pg/ml
 Anti-GBM antibody <10 U/ml
 Antinuclear antibody <×40
 Anti-ds-DNA antibody <1.2 IU/ml
 Anti-SS-A antibody <1.0 U/ml
 Anti-SS-B antibody <1.0 U/ml
 Anti-Scl-70 antibody <1.0 U/ml
 Anti-Jo-1 antibody −
 MPO-ANCA <1.0 U/ml




 Occult blood –
Bronchoalveolar lavage (rt.B4a)
 Recovery rate 53.3% (80/150 ml)




 Neutrophils 78.8% (H)
 Siderophages 1.9%
PT-INR prothrombin time-international normalized ratio, APTT activated partial 
thromboplastin time, KL-6 sialylated carbohydrate antigen KL-6, anti-GBM anti-
body anti-anti-glomerular basement membrane antibody, anti-ds-DNA antibody 
anti-double stranded DNA, anti-SS-A antibody anti-Sjögren’s-syndrome-related 
antigen A antibody, anti-SS-B antibody anti-Sjögren’s-syndrome-related antigen 
B antibody, anti-Scl-70 antibody anti-scleroderma-70 antibody, anti-Jo-1 antibody 
anti-histidyl tRNA synthetase antibody, MPO-ANCA myeloperoxidase-antineutro-
phil cytoplasmic antibody, PR3-ANCA proteinase 3- antineutrophil cytoplasmic 




 Mycobacterium tuberculosis −
 Cytology Class II
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water repellents in waterproofing sprays are responsi-
ble for causing the acute respiratory illness following 
inhalation. The primary structural changes after inhala-
tion of waterproofing sprays in animals include alveo-
lar type I cell necrosis and alveolar type II cell necrosis, 
with resultant impairment of surfactant secretion, direct 
counteraction of surfactant action, alveolar atelecta-
sis and hemorrhage (Hays and Spiller 2014). A recent 
study reported developing an isolated perfused rat lung 
model to examine the potential of surface tension-active 
substances in waterproofing sprays to cause pulmonary 
collapse (Fischer et  al. 2012). Other mechanisms of the 
toxicity of waterproofing sprays include an indirect and 
complex mechanism requiring metabolic activation 
with or without interaction with other factors, such as 
solvents (e.g., n-heptane, hexane and petroleum distil-
lates) and smoking (Hays and Spiller 2014). The mist par-
ticle size and the emission rate have also been shown to 
influence the toxicity of waterproofing sprays (Hays and 
Spiller 2014; Yamashita et al. 1997).
The commonest symptoms associated with inhalation 
of fluoropolymer-based waterproofing sprays include 
non-productive cough and dyspnea, often accompanied 
by flu-like symptoms (Vernez et al. 2006; Hays and Spiller 
2014). The illness develops rapidly, usually within min-
utes to hours (Vernez et al. 2006; Hays and Spiller 2014). 
Similar to the case reported herein, there is one previ-
ous report of DAH resulting from inhalation of a water-
proofing spray (Fukui et  al. 2011). Laboratory studies 
generally reveal evidence of acute inflammation such as 
Figure 1 A radiograph (left) and high resolution CT scan (right) of the chest showing bilateral ground glass opacities.
Figure 2 Bloody gross appearance (left) and microscopic findings (right) of bronchoalveolar lavage fluid specimens. Right May-Giemsa-stained 
cytospin preparation showing numerous red blood cells and neutrophils, consistent with the diagnosis of alveolar hemorrhage. Arrows mac-
rophages. Scale bar 50 μm.
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leukocytosis and elevated serum CRP (Hays and Spiller 
2014). In one previous case report, marked hypocalcemia 
was observed in the patient, which was attributed to the 
binding activity of fluoride to cations, such as calcium 
(Bracco and Favre 1998). Serious outcomes and death are 
uncommon (Vernez et  al. 2006; Hays and Spiller 2014). 
Most victims, even those that present DAH, like our 
patient, improved with supportive care, with or without 
corticosteroid and inhaled β2 adrenergic agonist therapy 
(Vernez et  al. 2006; Fukui et  al. 2011; Hays and Spiller 
2014).
Conclusions
Accidental inhalation of waterproofing sprays may cause 
diffuse alveolar hemorrhage, a rare manifestation of acute 
lung injury. Supportive treatment may be effective and 
sufficient.
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